» Authors » Hiroaki Kawasaki

Hiroaki Kawasaki

Explore the profile of Hiroaki Kawasaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 91
Citations 1126
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Masuda M, Waters B, Gotoh L, Nakamura Y, Kato Y, Nabeshima S, et al.
Neuropsychopharmacol Rep . 2024 Oct; 44(4):809-820. PMID: 39467092
Background: While drugs are sometimes taken during deliberate self-harm (DSH), no study has attempted to analyze drugs in the blood of DSH patients and compare them with prescribed medications or...
2.
Asada R, Hori H, Gotoh L, Yasumatsu K, Iida H, Kawasaki H
J Psychiatr Res . 2024 Jul; 177:299-304. PMID: 39059027
We investigated the plasma tumor necrosis factor (TNF)-α levels between patients with schizophrenia remission and healthy controls, and the association between the plasma TNF-α levels and cognitive function and social...
3.
4.
Hamada F, Hori H, Iida H, Yokoyama H, Sugawara H, Hatanaka A, et al.
Metabolites . 2023 Sep; 13(9). PMID: 37755261
Treatment of bipolar disorder is prone to prolongation despite various treatments, including medication. The efficacy of exercise treatment (i.e., interventions involving physical exercise and sports intervention) for major depressive disorders...
5.
Hatsuda M, Kawasaki H, Shigenaga A, Taketani A, Takanashi T, Wakabayashi Y, et al.
Sci Rep . 2023 Aug; 13(1):12479. PMID: 37528144
The impact of deep space cosmic rays on food resources is as important as the risks of cosmic rays to the human body. This study demonstrates the potential for neutrons...
6.
Kimura H, Kishi S, Narita H, Tanaka T, Okada T, Fujisawa D, et al.
BMC Gastroenterol . 2023 Apr; 23(1):106. PMID: 37020184
Objective: Comorbid psychiatric disorders negatively affect the survival rate of patients with some physical disorders. In liver transplant recipients, various psychiatric disorders have been identified as worsening prognosis. However, little...
7.
Nakao T, Murayama K, Fukuda H, Eto N, Fujita K, Igata R, et al.
Brain Behav Immun Health . 2023 Apr; 29:100615. PMID: 37008742
Physical symptoms such as fatigue and muscle weakness, and psychiatric symptoms like depression and anxiety are considered as complications and sequelae of COVID-19. This epidemiological study investigated the actual status...
8.
Iida H, Okada T, Nemoto K, Hasegawa N, Numata S, Ogasawara K, et al.
Neuropsychopharmacol Rep . 2022 Nov; 43(1):23-32. PMID: 36444167
To disseminate, educate, and validate psychiatric clinical practice guidelines, the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project was launched in 2016. In this study, we...
9.
Hori H, Yasui-Furukori N, Hasegawa N, Iga J, Ochi S, Ichihashi K, et al.
Front Psychiatry . 2022 Jun; 13:823826. PMID: 35656353
In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not recommended. We investigated the characteristics of the use of anticholinergics in patients with schizophrenia by considering psychotropic...
10.
Asada R, Ogushi Y, Hori H, Kawasaki H
Psychogeriatrics . 2022 Feb; 22(3):413-414. PMID: 35141987
No abstract available.